* Neximmune Inc NEXI.OQ reported a quarterly adjusted loss
of 65 cents per share for the quarter ended in September. The
mean expectation of three analysts for the quarter was for a
loss of 64 cents per share.
* Reported revenue was zero; analysts expected zero.
* Neximmune Inc's reported EPS for the quarter was a loss of 65
cents.
* The mean earnings estimate of analysts had risen by about 1%
in the last three months.
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company.
* Neximmune Inc shares had fallen by 25.5% this quarter.
* The company reported a quarterly loss of $14.65 million.
* Wall Street's median 12-month price target for Neximmune Inc
is $35.00
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 3 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."
This summary was machine generated November 13 at 08:50 a.m.
All figures in US dollars unless otherwise stated